Bortezomib and Arsenic Trioxide Activity on a Myelodysplastic Cell Line (P39): A Gene Expression Study

SAVLI H., Galimberti S., Sunnetci D., Canestraro M., Palumbo G., Nagy B., ...More

TURKISH JOURNAL OF HEMATOLOGY, vol.32, no.3, pp.206-212, 2015 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 32 Issue: 3
  • Publication Date: 2015
  • Doi Number: 10.4274/tjh.2014.0058
  • Journal Name: TURKISH JOURNAL OF HEMATOLOGY
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, TR DİZİN (ULAKBİM)
  • Page Numbers: pp.206-212
  • Kocaeli University Affiliated: Yes

Abstract

Objective: We aimed to understand the molecular pathways affected by bortezomib and arsenic trioxide treatment on myelomonocytoid cell line P39.